A new study has found a new treatment approach that could offer hope to patients with the aggressive blood cancer acute myeloid leukaemia (AML).
New Leukaemia Drug Kills 90pc of Cancer in First Dose
New leukaemia drug has given hope to patients as it kills nearly 90 per cent of their cancer in the first dose.
New leukaemia drug has given hope to patients as it kills nearly 90 per cent of their cancer in the first dose.
Lane continued that it did this by inhibiting a protein needed for the formation of the leukaemia stem cells, which otherwise have enormous self-renewal capacity.
Lane said that the study found that by turning off a gene called telomerase, the cancer cells became unstable and eventually the cells died.
CNIO Researchers Link 2 Oncogenes With the Agressiveness and Incidence of Leukaemia in Mice
Ongoing clinical trials are currently studying inhibitors for two proteins, Cdk4 and Cdk6, targeting several types of cancer, such as breast cancer, lung cancer and leukaemia.
Ongoing clinical trials are currently studying inhibitors for two proteins, Cdk4 and Cdk6, targeting several types of cancer, such as breast cancer, lung cancer and leukaemia.
The study has been published in Cell Stem Cell.
Advertisements
7-year-old Boy With Leukaemia Learns He's Going Home
Heartwarming moment of 7-year-old boy with leukaemia captured on video
Heartwarming moment of 7-year-old boy with leukaemia captured on video
Leukaemia Risk Not Linked to Living Under Overhead Power Lines
Children living near overhead power lines don't have an increased risk of developing leukaemia, a new study revealed
Children living near overhead power lines don't have an increased risk of developing leukaemia, a new study revealed
